Categories: News

Bemax Inc. Retires 600 Million Common Shares of Company Stock, Reduce Issued and Outstanding Shares

  • Total issued and outstanding reduced by 55.01%

Dallas, Georgia–(Newsfile Corp. – October 3, 2024) – Bemax Inc. (OTC Pink: BMXC), a private label development company with a focus on disposable diapers and women’s hygienic sanitary products, is pleased to announce today its CEO, Taiwo Aimasiko, has voluntarily retired 600,000,000 million Common Shares of the Company’s Stock for 24,000,000 Series “B” preferred shares effectively reducing the total issued and outstanding common shares by 55.01%.

This share retirement is the first as an additional reduction of the total shares outstanding will be effected during the current fiscal year.

“By retiring 600 million common shares we instantly create additional value to the shareholders & health of the company. The return of these shares demonstrates management’s desire to maintain a capital structure that supports growth without resorting to increasing our authorized shares. This continues to be an integral part of Bemax Inc.’s long term corporate strategy,” said Taiwo Aimasiko, CEO of Bemax Inc.

“At Bemax, we continue to commit to a growth-oriented approach to enhance shareholders value and confidence as we execute plans that would support projected sales targets”, stated Bemax CEO, Taiwo Aimasiko.

This press release is in reference to the form 4 document filed with the SEC on October 1, 2024.

About Bemax Inc.

About Bemax Inc. Bemax Inc. is a forward-thinking company dedicated to delivering top-quality disposable diapers and women’s hygienic sanitary products. With a focus on innovation and customer satisfaction, Bemax continues to expand its product offerings and distribution network, aiming to exceed the expectations of its growing customer base. Bemax Inc. exports and distribute private label household products to the global emerging markets. www.bemaxinc.com.

Safe Harbor Statement

This press release contains forward-looking statements that can be identified by terminology such as “believes,” “expects,” “potential,” “plans,” “suggests,” “may,” “should,” “could,” “intends,” or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results or implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company’s control. Forward-looking statements speak only as to the date they are made and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/225404

Staff

Recent Posts

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

17 hours ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

17 hours ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

17 hours ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

17 hours ago

Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger

CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or…

17 hours ago

Park Dental Partners Announces Dates for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading…

17 hours ago